Anteris Technologies Global Corp. — Capital/Financing Update 2016

Sep 5, 2016

==> picture [231 x 86] intentionally omitted <==

6 September 2016

Centralised Company Announcements Platform Australian Stock Exchange 10th floor, 20 Bond Street Sydney NSW 2000

Admedus Ltd ABN 35 088 221 078 REGISTERED OFFICE: 26 Harris Road Malaga Western Australia 6090 PO Box 6879 East Perth Western Australia 6892 T +61 (0)8 9266 0100 F +61 (0)8 9266 0199 E info.au@admedus.com www.admedus.com

Dear Sir / Madam,

Appendix 3B - Shortfall

The Board of Directors of Admedus Ltd hereby announces that 8,889,524 fully paid ordinary shares have now been allotted upon the clearing of receipts totalling $2,933,542.92. This represents the balance of the Offer which was placed by Paterson Securities Limited in accordance with the Underwriting Agreement.

Refer to the attached Appendix 3B.

Computershare Investor Services Pty Ltd Telephone: 1300 850 505 (within Australia) +61 (0) 3 9415 4000 (outside Australia)

Yours sincerely For and on behalf of Admedus Limited

==> picture [148 x 59] intentionally omitted <==

Stephen Mann Company Secretary

==> picture [595 x 44] intentionally omitted <==

Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

Name of entity

ADMEDUS LIMITED

ABN 35 088 221 078

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the+securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)	Ordinary shares fully paid
	8,889,524 ordinary shares fully paid (New Shares) pursuant to the Company's renounceable entitlement offer (Entitlement Offer)
	Ordinary shares fully paid ranking equally with existing ordinary shares fully paid.

• See chapter 19 for defined terms.

Appendix 3B Page 2

01/08/2012

4 Do the+securities rank equally in all respects from the date of allotment with an existing+class of quoted+securities? If the additional securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed 6c Number of+securities issued without security holder approval under rule 7.1 6d Number of+securities issued with security holder approval under rule 7.1A	Yes
	$0.33 per New Share totaling $2,933,542.92
	The purpose of the Entitlement Offer is outlined in the Company’s announcement dated 29 July 2016 and the prospectus dated 2 August 2016
	Yes
	13 November 2015
	N/A
	N/A

• See chapter 19 for defined terms.

Appendix 3B Page 3

01/08/2012

6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of securities issued under an exception in rule 7.2 6g If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation. 6h If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 Dates of entering+securities into uncertificated holdings or despatch of certificates 8 Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable)	N/A	N/A
	8,889,524 (Exemption 1)
	N/A
	N/A
	Listing Rule 7.1 capacity: 8,414,098 Listing Rule 7.1A capacity: 2,517,387
	5 September 2016
	Number	+Class
	251,731,693	Ordinary Shares

• See chapter 19 for defined terms.

Appendix 3B Page 4

01/08/2012

9 Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable) 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)	Number	+Class
	213,334 200,000 1,505,007 300,000 1,500,000 900,000 200,000 410,000 1,885,000 1,350,000 200,000 475,000 5,250,000 380,000 250,000	18/05/17 $0.60 options 01/03/18 $0.60 options 18/06/18 $0.95 options 01/07/18 $1.70 options 21/05/19 $1.70 options 16/12/18 $2.70 options 01/02/19 $2.45 options 05/11/19 $2.10 options 30/06/20 $1.17 options 21/07/20 $1.44 options 10/12/20 $1.39 options 10/12/20 $0.83 options 18/12/20 $0.79 warrants 23/12/20 $0.79 warrants 24/06/21 $0.30 options
	N/A

• See chapter 19 for defined terms.

Appendix 3B Page 5

01/08/2012

Part 2 - Bonus issue or pro rata issue

11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has+security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations	No
	Renounceable
	1 New Share for every 9 held at the record date
	Ordinary shares
	15 August 2016
	No
	Any fractional entitlement will be rounded up to nearest whole share
	All countries except Australia, New Zealand, Singapore and the United Kingdom
	29 August 2016 (3pm WST)

• See chapter 19 for defined terms.

Appendix 3B Page 6

01/08/2012

20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of+security holders 25 If the issue is contingent on +security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) 30 How do+security holders sell their entitlements_in full_through a broker?	Patersons Securities Ltd
	A management fee of 1.0% of the total gross amount raised in relation to the Entitlement Offer and a selling fee of 4.5% of the total gross amount raised in relation to the Entitlement Offer
	N/A
	N/A
	N/A
	N/A
	18 August 2016
	1 August 2016
	12 August 2016
	22 August 2016
	Eligible Shareholders who wish to sell their entitlements in full on ASX through a broker should instruct their stockbroker personally and provide the details requested, as set out in the Entitlement and Acceptance Form. All ASX sales of entitlements must be made by close of the rights trading period 22 August 2016

• See chapter 19 for defined terms.

Appendix 3B Page 7

01/08/2012

31 How do+security holders sell_part_ of their entitlements through a broker and accept for the balance?

Eligible Shareholders who wish to sell part of their entitlement through a broker and accept for the balance must:  in respect of the part of their entitlement being taken up, complete and return the Entitlement and Acceptance Form to the Registry along with the required Application Monies (being the issue price of $0.33 multiplied by the number of New Shares accepted; and  in respect of the part of the entitlement to be sold, instruct their stockbroker personally and provide details requested, as set out in the Entitlement and Acceptance Form. All ASX sales of entitlements must be made by close of the rights trading period on 22 August 2016.

• See chapter 19 for defined terms.

Appendix 3B Page 8

01/08/2012

32 How do[+] security holders dispose Eligible Shareholders who wish to transfer all or of their entitlements (except by part of their entitlement to another person other sale through a broker)? than on ASX (provided the purchaser has an address in Australia, New Zealand, Singapore and the United Kingdom and is not in the United States or acting for the account or benefit of a person in the United States) must:  if they are a shareholder on the issuer sponsored subregister, forward a completed standard renunciation and transfer form to the Registry along with the transferee’s required Application Monies (being the issue price of $0.33 multiplied by the number of New Shares they wish to subscribe for); and  If they wish to transfer all or proportion of their entitlement to another person on the CHESS subregister, they must engage their CHESS controlling participant (usually their stockbroker).

• 33 +Despatch date 6 September 2016

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of securities ( tick one )

• (a)[Securities described in Part 1 ]

• (b)[All other securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

• See chapter 19 for defined terms.

Appendix 3B Page 9

01/08/2012

N/A

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over N/A 37 A copy of any trust deed for the additional[+] securities N/A

• See chapter 19 for defined terms.

Appendix 3B Page 10

01/08/2012

Entities that have ticked box 34(b)

38 Number of securities for which +quotation is sought 39 Class of +securities for which quotation is sought 40 Do the+securities rank equally in all respects from the date of allotment with an existing+class of quoted+securities? If the additional securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) 42 Number and +class of all +securities quoted on ASX (_including_the securities in clause 38)	N/A
	N/A
	N/A
	N/A
	Number	+Class
	N/A	N/A

• See chapter 19 for defined terms.

Appendix 3B Page 11

01/08/2012

Quotation agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted[+] quotation.

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that noone has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ... ............. ...............................

Date: 6 September 2016

Company secretary

Print name: ..Stephen Mann.......................................................

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for[+] eligible entities

Introduced 01/08/12

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [404 x 379] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid ordinary 184,716,306
securities on issue 12 months before date
of issue or agreement to issue
Add the following:
• Number of fully paid ordinary securities 25,197,864
issued in that 12 month period under an
exception in rule 7.2
216,373
• Number of fully paid ordinary securities
issued in that 12 month period with
shareholder approval
0
• Number of partly paid ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid ordinary Nil
securities cancelled during that 12 month
period
“A” 210,130,543
----- End of picture text -----

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A”	Step 2: Calculate 15% of “A”
“B”	0.15 [Note: this value cannot be changed]
Multiply“A” by 0.15	31,519,581
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used
Insertnumber of equity securities issued or agreed to be issued in that 12 month period_not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items	23,105,483
“C”	23,105,483
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
“A” x 0.15 Note: number must be same as shown in Step 2	31,519,581
Subtract“C” Note: number must be same as shown in Step 3	23,105,483
Total[“A” x 0.15] – “C”	8,414,098 [Note: this is the remaining placement capacity under rule 7.1]

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 210,130,543 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 21,013,054

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued 18,495,667 or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities – not just ordinary securities

• Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• • It may be useful to set out issues of securities on different dates as separate line items

“E” 18,495,667

==> picture [221 x 85] intentionally omitted <==

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A	Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2	21,013,054
Subtract“E” Note: number must be same as shown in Step 3	18,495,667
Total[“A” x 0.10] – “E”	2,517,387 Note: this is the remaining placement capacity under rule 7.1A